SuperworthOragenics shares outstanding OGEN
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 4.4M
- On a year earlier
- +505.1%
- more shares
Oragenics had 4.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 505.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 4.2M | +964% |
| FY2024 | 395.9K | +359% |
| FY2023 | 86.2K | +17% |
| FY2022 | 73.6K | +14% |
| FY2021 | 64.7K | +71% |
| FY2020 | 37.7K | +47% |
| FY2019 | 25.6K | +59% |
| FY2018 | 16.1K | +488% |
| FY2017 | 2.7K | +0% |
| FY2016 | 2.7K | +31% |
| FY2015 | 2.1K | +4% |
| FY2014 | 2K | +11% |
| FY2013 | 1.8K | +20% |
| FY2012 | 1.5K | +364% |
| FY2011 | 325 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4.4M | +505% | |
| Q1 FY26 | 4.3M | +608% | |
| Q4 FY25 | 4.2M | +964% | |
| Q3 FY25 | 1.6M | +617% | |
| Q2 FY25 | 731.8K | +385% | |
| Q1 FY25 | 607.2K | +421% | |
| Q4 FY24 | 395.9K | +359% | |
| Q3 FY24 | 217.6K | +177% | |
| Q2 FY24 | 151K | +124% | |
| Q1 FY24 | 116.5K | +59% | |
| Q4 FY23 | 86.2K | +17% | |
| Q3 FY23 | 78.5K | +21% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Oragenics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.